Matthew Herper is a senior editor at Forbes where he is in charge of pharmaceutical and healthcare coverage both in the magazine and online. He started at Forbes in 2000, when Celera genomics was a white-hot stock, and has lived through the biotechnology industry’s booms and busts ever since. Along the way he has write cover stories on overzealous drug marketing, antibiotic resistance, and genomics, profiling Jonathan Rothberg, Jay Flatley, Bill Gates, Paul Allen, and George Church. He was among the first reporters to call attention to a buried clinical trial that caused sales of Merck’s Vytorin to plummet, and his analyses of R&D productivity have been used by in investor presentations by Novartis, and Johnson & Johnson. Matthew has a Bachelor of Science degree from Massachusetts Institute of Technology and a Master of Science in journalism from Columbia University.
Thomas Scully is a general partner at Welsh, Carson, Anderson & Stowe. Prior to joining WCAS, he was the administrator of the Centers for Medicare & Medicaid Services for three years under President George W. Bush and the president and CEO of the Federation of American Hospitals for six years. He also served as the deputy assistant to the president and as the associate director of OMB under President George H.W. Bush, and he has practiced law at Alston and Bird; Patton Boggs; and Akin, Gump, Strauss Hauer and Feld. Tom received a B.A. from the University of Virginia in 1979 and a J.D. from Catholic University in 1986.
Anu Singh is Managing Director of Kaufman Hall, where he provides financial advisory services to healthcare organizations and companies nationwide. Mr. Singh leads the evaluation, structuring, negotiation, and execution of mergers, acquisitions, partnerships, joint ventures, and other forms of transactions. He also leads projects involving the assessment of strategic options, growth strategies and business unit/segment viability. His clients include national and large multi-regional health systems, academic medical centers, community hospitals, large physician practices and groups, health insurers, non-acute care providers, and capital providers to health care entities. Prior to joining Kaufman Hall, Mr. Singh was a Director at Huron Consulting Group, within its Corporate Advisory Services practice. His previous experience includes the execution of turnaround and restructuring plans, and advising on mergers, acquisitions, and other transactions. Mr. Singh also has raised capital for a variety of clients, ranging from underperforming or distressed companies to well-capitalized, investment-grade companies across multiple industries. He has extensive overseas work experience, particularly on behalf of aid agencies, Central Banks, and other parties involved in major financial markets. Mr. Singh has presented at various industry and professional events and seminars, including those sponsored by The Governance Institute, Healthcare Financial Management Association, Voluntary Hospital Association, Becker’s Hospital Review, National Federation of Municipal Analysts, and the Turnaround Management Association. Mr. Singh has an M.B.A. from Northwestern University’s Kellogg School of Management and a B.S. in Finance from the University of Illinois at Urbana-Champaign. He also holds CPA, CFA, CTP, CIRA, and CDBV certifications.
Chapin White is a senior policy researcher at the RAND Corporation, specializing in health economics, and a Pardee RAND Graduate School faculty member. His work combines quantitative and qualitative methods and focuses on provider payment reform and the implementation and impacts of the Affordable Care Act (ACA). Dr. White is currently leading the development and application of RAND’s Health Care Payment and Delivery Simulation Model (PADSIM), and recently completed an analysis of health reform options for the state of Oregon. In other recent work, Dr. White has analyzed the spillover effects of Accountable Care Organizations (ACOs) on the Medicare fee-for-service program, out-of-network hospital care in New Jersey, and alternatives to the “Cadillac” tax using RAND’s COMPARE microsimulation model. Before joining RAND, Dr. White was a senior health researcher at the Center for Studying Health System Change (2010–2013), and a principal analyst at the Congressional Budget Office (2005–2010). Dr. White holds a Ph.D. in health policy from Harvard University.
Sarah J Dash is the president and chief executive officer at the Alliance for Health Policy. She drives the mission and vision of the Alliance, as well as advances and maintains the reputation of the organization as the leading nonpartisan resource for policymakers and health leaders in an evolving health policy environment. Sarah joined the Alliance in 2014 as the vice president for policy and became president and CEO in May 2017. Sarah has long been an influential force in shaping health policy, having served as a senior aide on Capitol Hill and as a member of the research faculty at the Georgetown University Health Policy Institute’s Center on Health Insurance Reforms. Sarah holds a master’s degree in public health from Yale School of Public Health and a Bachelor of Science in chemistry and literature from MIT.